Dusa, River's Edge Settle Acne Drug Patent Dispute

Law360 (October 29, 2007, 12:00 AM EDT) -- River's Edge LLC has agreed to permanently cease making and selling a generic version of Dusa Pharmaceuticals Inc.'s acne treatment Nicomide as part of a settlement that will put to rest a patent infringement lawsuit brought against River's Edge in April 2006.

In addition to stopping the manufacture and sale of its nicotinamide product NIC 750, River's Edge will make a lump-sum payment to Dusa, and concede that Dusa's patent is valid and enforceable, Dusa said Monday.

River's Edge will also stop participating in the re-examination...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.